ID   SIR2_YEAST              Reviewed;         562 AA.
AC   P06700; D6VRV4;
DT   01-JAN-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1988, sequence version 1.
DT   18-JUN-2025, entry version 238.
DE   RecName: Full=NAD-dependent histone deacetylase SIR2;
DE            EC=2.3.1.286 {ECO:0000255|PROSITE-ProRule:PRU00236};
DE   AltName: Full=Regulatory protein SIR2;
DE   AltName: Full=Silent information regulator 2;
GN   Name=SIR2; Synonyms=MAR1; OrderedLocusNames=YDL042C; ORFNames=D2714;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina; Saccharomycetes;
OC   Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=6098447; DOI=10.1002/j.1460-2075.1984.tb02214.x;
RA   Shore D., Squire M., Nasmyth K.A.;
RT   "Characterization of two genes required for the position-effect control of
RT   yeast mating-type genes.";
RL   EMBO J. 3:2817-2823(1984).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=9046088;
RX   DOI=10.1002/(sici)1097-0061(199701)13:1<65::aid-yea50>3.0.co;2-t;
RA   Saren A.-M., Laamanen P., Lejarcegui J.B., Paulin L.;
RT   "The sequence of a 36.7 kb segment on the left arm of chromosome IV from
RT   Saccharomyces cerevisiae reveals 20 non-overlapping open reading frames
RT   (ORFs) including SIT4, FAD1, NAM1, RNA11, SIR2, NAT1, PRP9, ACT2 and MPS1
RT   and 11 new ORFs.";
RL   Yeast 13:65-71(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=9169867; DOI=10.1038/387s075;
RA   Jacq C., Alt-Moerbe J., Andre B., Arnold W., Bahr A., Ballesta J.P.G.,
RA   Bargues M., Baron L., Becker A., Biteau N., Bloecker H., Blugeon C.,
RA   Boskovic J., Brandt P., Brueckner M., Buitrago M.J., Coster F.,
RA   Delaveau T., del Rey F., Dujon B., Eide L.G., Garcia-Cantalejo J.M.,
RA   Goffeau A., Gomez-Peris A., Granotier C., Hanemann V., Hankeln T.,
RA   Hoheisel J.D., Jaeger W., Jimenez A., Jonniaux J.-L., Kraemer C.,
RA   Kuester H., Laamanen P., Legros Y., Louis E.J., Moeller-Rieker S.,
RA   Monnet A., Moro M., Mueller-Auer S., Nussbaumer B., Paricio N., Paulin L.,
RA   Perea J., Perez-Alonso M., Perez-Ortin J.E., Pohl T.M., Prydz H.,
RA   Purnelle B., Rasmussen S.W., Remacha M.A., Revuelta J.L., Rieger M.,
RA   Salom D., Saluz H.P., Saiz J.E., Saren A.-M., Schaefer M., Scharfe M.,
RA   Schmidt E.R., Schneider C., Scholler P., Schwarz S., Soler-Mira A.,
RA   Urrestarazu L.A., Verhasselt P., Vissers S., Voet M., Volckaert G.,
RA   Wagner G., Wambutt R., Wedler E., Wedler H., Woelfl S., Harris D.E.,
RA   Bowman S., Brown D., Churcher C.M., Connor R., Dedman K., Gentles S.,
RA   Hamlin N., Hunt S., Jones L., McDonald S., Murphy L.D., Niblett D.,
RA   Odell C., Oliver K., Rajandream M.A., Richards C., Shore L., Walsh S.V.,
RA   Barrell B.G., Dietrich F.S., Mulligan J.T., Allen E., Araujo R., Aviles E.,
RA   Berno A., Carpenter J., Chen E., Cherry J.M., Chung E., Duncan M.,
RA   Hunicke-Smith S., Hyman R.W., Komp C., Lashkari D., Lew H., Lin D.,
RA   Mosedale D., Nakahara K., Namath A., Oefner P., Oh C., Petel F.X.,
RA   Roberts D., Schramm S., Schroeder M., Shogren T., Shroff N., Winant A.,
RA   Yelton M.A., Botstein D., Davis R.W., Johnston M., Andrews S., Brinkman R.,
RA   Cooper J., Ding H., Du Z., Favello A., Fulton L., Gattung S., Greco T.,
RA   Hallsworth K., Hawkins J., Hillier L.W., Jier M., Johnson D., Johnston L.,
RA   Kirsten J., Kucaba T., Langston Y., Latreille P., Le T., Mardis E.,
RA   Menezes S., Miller N., Nhan M., Pauley A., Peluso D., Rifkin L., Riles L.,
RA   Taich A., Trevaskis E., Vignati D., Wilcox L., Wohldman P., Vaudin M.,
RA   Wilson R., Waterston R., Albermann K., Hani J., Heumann K., Kleine K.,
RA   Mewes H.-W., Zollner A., Zaccaria P.;
RT   "The nucleotide sequence of Saccharomyces cerevisiae chromosome IV.";
RL   Nature 387:75-78(1997).
RN   [4]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M., Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [5]
RP   SUBCELLULAR LOCATION.
RX   PubMed=9214640; DOI=10.1093/emboj/16.11.3243;
RA   Gotta M., Strahl-Bolsinger S., Renauld H., Laroche T., Kennedy B.K.,
RA   Grunstein M., Gasser S.M.;
RT   "Localization of Sir2p: the nucleolus as a compartment for silent
RT   information regulators.";
RL   EMBO J. 16:3243-3255(1997).
RN   [6]
RP   PRELIMINARY FUNCTION.
RX   PubMed=10619427; DOI=10.1016/s0092-8674(00)81671-2;
RA   Tanny J.C., Dowd G.J., Huang J., Hilz H., Moazed D.;
RT   "An enzymatic activity in the yeast Sir2 protein that is essential for gene
RT   silencing.";
RL   Cell 99:735-745(1999).
RN   [7]
RP   FUNCTION.
RX   PubMed=10693811; DOI=10.1038/35001622;
RA   Imai S., Armstrong C.M., Kaeberlein M., Guarente L.;
RT   "Transcriptional silencing and longevity protein Sir2 is an NAD-dependent
RT   histone deacetylase.";
RL   Nature 403:795-800(2000).
RN   [8]
RP   FUNCTION.
RX   PubMed=9278054; DOI=10.1038/42288;
RA   Tsukamoto Y., Kato J., Ikeda H.;
RT   "Silencing factors participate in DNA repair and recombination in
RT   Saccharomyces cerevisiae.";
RL   Nature 388:900-903(1997).
RN   [9]
RP   INTERACTION WITH SIR3 AND SIR4.
RX   PubMed=9122169; DOI=10.1073/pnas.94.6.2186;
RA   Moazed D., Kistler A., Axelrod A., Rine J., Johnson A.D.;
RT   "Silent information regulator protein complexes in Saccharomyces
RT   cerevisiae: a SIR2/SIR4 complex and evidence for a regulatory domain in
RT   SIR4 that inhibits its interaction with SIR3.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:2186-2191(1997).
RN   [10]
RP   IDENTIFICATION IN A RENT COMPLEX WITH CDC14.
RX   PubMed=10219244; DOI=10.1016/s0092-8674(00)80733-3;
RA   Shou W., Seol J.H., Shevchenko A., Baskerville C., Moazed D., Chen Z.W.S.,
RA   Jang J., Shevchenko A., Charbonneau H., Deshaies R.J.;
RT   "Exit from mitosis is triggered by Tem1-dependent release of the protein
RT   phosphatase Cdc14 from nucleolar RENT complex.";
RL   Cell 97:233-244(1999).
RN   [11]
RP   IDENTIFICATION IN A RENT COMPLEX WITH NET1.
RX   PubMed=10219245; DOI=10.1016/s0092-8674(00)80734-5;
RA   Straight A.F., Shou W., Dowd G.J., Turck C.W., Deshaies R.J., Johnson A.D.,
RA   Moazed D.;
RT   "Net1, a Sir2-associated nucleolar protein required for rDNA silencing and
RT   nucleolar integrity.";
RL   Cell 97:245-256(1999).
RN   [12]
RP   INTERACTION WITH ZDS2.
RX   PubMed=10662670; DOI=10.1016/s0960-9822(00)00298-0;
RA   Roy N., Runge K.W.;
RT   "Two paralogs involved in transcriptional silencing that antagonistically
RT   control yeast life span.";
RL   Curr. Biol. 10:111-114(2000).
RN   [13]
RP   MECHANISM OF TRANSCRIPTION REPRESSION.
RX   PubMed=11348596; DOI=10.1016/s0092-8674(01)00329-4;
RA   Sekinger E.A., Gross D.S.;
RT   "Silenced chromatin is permissive to activator binding and PIC
RT   recruitment.";
RL   Cell 105:403-414(2001).
RN   [14]
RP   REVIEW.
RX   PubMed=11722841; DOI=10.1016/s0378-1119(01)00741-7;
RA   Gasser S.M., Cockell M.M.;
RT   "The molecular biology of the SIR proteins.";
RL   Gene 279:1-16(2001).
RN   [15]
RP   INTERACTION WITH ESC8.
RX   PubMed=12399377; DOI=10.1093/genetics/162.2.633;
RA   Cuperus G., Shore D.;
RT   "Restoration of silencing in Saccharomyces cerevisiae by tethering of a
RT   novel Sir2-interacting protein, Esc8.";
RL   Genetics 162:633-645(2002).
RN   [16]
RP   MUTAGENESIS OF ARG-139; GLY-270 AND PHE-296.
RX   PubMed=12399383; DOI=10.1093/genetics/162.2.721;
RA   Garcia S.N., Pillus L.;
RT   "A unique class of conditional sir2 mutants displays distinct silencing
RT   defects in Saccharomyces cerevisiae.";
RL   Genetics 162:721-736(2002).
RN   [17]
RP   FUNCTION, AND INTERACTION WITH FOB1.
RX   PubMed=12923057; DOI=10.1101/gad.1108403;
RA   Huang J., Moazed D.;
RT   "Association of the RENT complex with nontranscribed and coding regions of
RT   rDNA and a regional requirement for the replication fork block protein Fob1
RT   in rDNA silencing.";
RL   Genes Dev. 17:2162-2176(2003).
RN   [18]
RP   LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS].
RX   PubMed=14562106; DOI=10.1038/nature02046;
RA   Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A., Dephoure N.,
RA   O'Shea E.K., Weissman J.S.;
RT   "Global analysis of protein expression in yeast.";
RL   Nature 425:737-741(2003).
RN   [19]
RP   ACTIVITY REGULATION.
RX   PubMed=12939617; DOI=10.1038/nature01960;
RA   Howitz K.T., Bitterman K.J., Cohen H.Y., Lamming D.W., Lavu S., Wood J.G.,
RA   Zipkin R.E., Chung P., Kisielewski A., Zhang L.-L., Scherer B.,
RA   Sinclair D.A.;
RT   "Small molecule activators of sirtuins extend Saccharomyces cerevisiae
RT   lifespan.";
RL   Nature 425:191-196(2003).
RN   [20]
RP   FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=15274642; DOI=10.1021/bi049592e;
RA   Borra M.T., Langer M.R., Slama J.T., Denu J.M.;
RT   "Substrate specificity and kinetic mechanism of the Sir2 family of NAD+-
RT   dependent histone/protein deacetylases.";
RL   Biochemistry 43:9877-9887(2004).
RN   [21]
RP   INTERACTION WITH MCM10.
RX   PubMed=16328881; DOI=10.1007/s11033-005-2312-x;
RA   Douglas N.L., Dozier S.K., Donato J.J.;
RT   "Dual roles for Mcm10 in DNA replication initiation and silencing at the
RT   mating-type loci.";
RL   Mol. Biol. Rep. 32:197-204(2005).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   STRAIN=ADR376;
RX   PubMed=17330950; DOI=10.1021/pr060559j;
RA   Li X., Gerber S.A., Rudner A.D., Beausoleil S.A., Haas W., Villen J.,
RA   Elias J.E., Gygi S.P.;
RT   "Large-scale phosphorylation analysis of alpha-factor-arrested
RT   Saccharomyces cerevisiae.";
RL   J. Proteome Res. 6:1190-1197(2007).
RN   [23]
RP   FUNCTION, AND INTERACTION WITH SLX5/HEX3.
RX   PubMed=18086879; DOI=10.1128/mcb.01291-07;
RA   Darst R.P., Garcia S.N., Koch M.R., Pillus L.;
RT   "Slx5 promotes transcriptional silencing and is required for robust growth
RT   in the absence of Sir2.";
RL   Mol. Cell. Biol. 28:1361-1372(2008).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18407956; DOI=10.1074/mcp.m700468-mcp200;
RA   Albuquerque C.P., Smolka M.B., Payne S.H., Bafna V., Eng J., Zhou H.;
RT   "A multidimensional chromatography technology for in-depth phosphoproteome
RT   analysis.";
RL   Mol. Cell. Proteomics 7:1389-1396(2008).
RN   [25]
RP   FUNCTION.
RX   PubMed=19220062; DOI=10.1021/bi802093g;
RA   Du J., Jiang H., Lin H.;
RT   "Investigating the ADP-ribosyltransferase activity of sirtuins with NAD
RT   analogues and 32P-NAD.";
RL   Biochemistry 48:2878-2890(2009).
RN   [26]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19779198; DOI=10.1126/science.1172867;
RA   Holt L.J., Tuch B.B., Villen J., Johnson A.D., Gygi S.P., Morgan D.O.;
RT   "Global analysis of Cdk1 substrate phosphorylation sites provides insights
RT   into evolution.";
RL   Science 325:1682-1686(2009).
RN   [27]
RP   INTERACTION WITH NSI1.
RX   PubMed=22362748; DOI=10.1093/nar/gks188;
RA   Ha C.W., Sung M.K., Huh W.K.;
RT   "Nsi1 plays a significant role in the silencing of ribosomal DNA in
RT   Saccharomyces cerevisiae.";
RL   Nucleic Acids Res. 40:4892-4903(2012).
RN   [28]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 209-562 IN COMPLEX WITH ZINC AND
RP   NICOTINAMIDE.
RA   Hall B.E., Buchberger J.R., Gerber S.A., Ambrosio A.L.B., Gygi S.P.,
RA   Filman D., Moazed D., Ellenberger T.;
RT   "Autoregulation of the yeast Sir2 deacetylase by reaction and trapping of a
RT   pseudosubstrate motif in the active site.";
RL   Submitted (JUN-2006) to the PDB data bank.
RN   [29]
RP   X-RAY CRYSTALLOGRAPHY (2.90 ANGSTROMS) OF 87-562 IN COMPLEX WITH SIR4;
RP   ADP-RIBOSE AND ZINC.
RX   PubMed=23307867; DOI=10.1101/gad.208140.112;
RA   Hsu H.C., Wang C.L., Wang M., Yang N., Chen Z., Sternglanz R., Xu R.M.;
RT   "Structural basis for allosteric stimulation of Sir2 activity by Sir4
RT   binding.";
RL   Genes Dev. 27:64-73(2013).
CC   -!- FUNCTION: NAD-dependent deacetylase, which participates in a wide range
CC       of cellular events including chromosome silencing, chromosome
CC       segregation, DNA recombination and the determination of life span.
CC       Involved in transcriptional repression of the silent mating-type loci
CC       HML and HMR and telomeric silencing via its association with SIR3 and
CC       SIR4. Plays a central role in ribosomal DNA (rDNA) silencing via its
CC       association with the RENT complex, preventing hyperrecombination, and
CC       repressing transcription from foreign promoters, which contributes to
CC       extending life span. Probably represses transcription via the formation
CC       of heterochromatin structure, which involves the compaction of
CC       chromatin fiber into a more condensed form, although this complex in at
CC       least one case can still bind euchromatic levels of positive
CC       transcription regulators. Although it displays some NAD-dependent
CC       histone deacetylase activity on histone H3K9Ac and H3K14Ac and histone
CC       H4K16Ac in vitro, such activity is unclear in vivo and may not be
CC       essential. {ECO:0000269|PubMed:10693811, ECO:0000269|PubMed:12923057,
CC       ECO:0000269|PubMed:15274642, ECO:0000269|PubMed:18086879,
CC       ECO:0000269|PubMed:19220062, ECO:0000269|PubMed:9278054}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N(6)-acetyl-L-lysyl-[protein] + NAD(+) + H2O = 2''-O-acetyl-
CC         ADP-D-ribose + nicotinamide + L-lysyl-[protein];
CC         Xref=Rhea:RHEA:43636, Rhea:RHEA-COMP:9752, Rhea:RHEA-COMP:10731,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:17154, ChEBI:CHEBI:29969,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:61930, ChEBI:CHEBI:83767;
CC         EC=2.3.1.286; Evidence={ECO:0000255|PROSITE-ProRule:PRU00236};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000269|PubMed:23307867};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000269|PubMed:23307867};
CC   -!- ACTIVITY REGULATION: Its activity is increased by calorie restriction,
CC       which slows the pace of aging and increases maximum lifespan. Activated
CC       by resveratrol (3,5,4'-trihydroxy-trans-stilbene), which is found in
CC       red wine. {ECO:0000269|PubMed:12939617}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=29.3 uM for NAD(+) {ECO:0000269|PubMed:15274642};
CC         KM=239 uM for a synthetic histone H3K9 acetyllysine peptide
CC         {ECO:0000269|PubMed:15274642};
CC         KM=420 uM for a synthetic histone H3K14 acetyllysine peptide
CC         {ECO:0000269|PubMed:15274642};
CC         KM=140 uM for a synthetic histone H4K5 acetyllysine peptide
CC         {ECO:0000269|PubMed:15274642};
CC         KM=54 uM for a synthetic histone H4K8 acetyllysine peptide
CC         {ECO:0000269|PubMed:15274642};
CC         KM=105 uM for a synthetic histone H4K12 acetyllysine peptide
CC         {ECO:0000269|PubMed:15274642};
CC         KM=17 uM for a synthetic histone H4K16 acetyllysine peptide
CC         {ECO:0000269|PubMed:15274642};
CC   -!- SUBUNIT: Homomultimer. Forms a complex with SIR3 and SIR4
CC       (PubMed:9122169). Component of the RENT complex, at least composed of
CC       SIR2, CDC14 and NET1 (PubMed:10219244, PubMed:10219245). The RENT
CC       complex interacts with FOB1 (PubMed:12923057). Interacts with ESC8
CC       (PubMed:12399377). Interacts with and ZDS2 (PubMed:10662670). Interacts
CC       with MCM10 (PubMed:16328881). Interacts with SLX5 (PubMed:18086879).
CC       Interacts with NSI1 (PubMed:22362748). {ECO:0000269|PubMed:10219244,
CC       ECO:0000269|PubMed:10219245, ECO:0000269|PubMed:10662670,
CC       ECO:0000269|PubMed:12399377, ECO:0000269|PubMed:12923057,
CC       ECO:0000269|PubMed:16328881, ECO:0000269|PubMed:18086879,
CC       ECO:0000269|PubMed:22362748, ECO:0000269|PubMed:9122169}.
CC   -!- INTERACTION:
CC       P06700; Q00684: CDC14; NbExp=6; IntAct=EBI-17219, EBI-4192;
CC       P06700; P22146: GAS1; NbExp=2; IntAct=EBI-17219, EBI-7327;
CC       P06700; P11978: SIR4; NbExp=8; IntAct=EBI-17219, EBI-17237;
CC   -!- SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:9214640}.
CC       Note=Associated with nucleolar chromatin. Preferentially bound to the
CC       spacer regions of the rDNA repeats through its interaction with NET1.
CC   -!- MISCELLANEOUS: Its stability is directly linked to life span, which is
CC       extended when it is present in high dosage. Conversely, its absence
CC       shortens life span.
CC   -!- MISCELLANEOUS: The reported ADP-ribosyltransferase activity of sirtuins
CC       is likely some inefficient side reaction of the deacetylase activity
CC       and may not be physiologically relevant. {ECO:0000305|PubMed:19220062}.
CC   -!- MISCELLANEOUS: Present with 3350 molecules/cell in log phase SD medium.
CC       {ECO:0000269|PubMed:14562106}.
CC   -!- SIMILARITY: Belongs to the sirtuin family. Class I subfamily.
CC       {ECO:0000305}.
CC   -!- CAUTION: Was originally thought to be an ADP-ribosyltransferase.
CC       {ECO:0000305|PubMed:10619427}.
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=In vino vita? - Issue 40 of
CC       November 2003;
CC       URL="https://www.proteinspotlight.org/back_issues/040";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X01419; CAA25667.1; -; Genomic_DNA.
DR   EMBL; Z71781; CAA96447.1; -; Genomic_DNA.
DR   EMBL; Z74090; CAA98600.1; -; Genomic_DNA.
DR   EMBL; BK006938; DAA11814.1; -; Genomic_DNA.
DR   PIR; S05891; RGBYS2.
DR   RefSeq; NP_010242.1; NM_001180101.1.
DR   PDB; 2HJH; X-ray; 1.85 A; A/B=209-562.
DR   PDB; 4IAO; X-ray; 2.90 A; A/B=87-562.
DR   PDBsum; 2HJH; -.
DR   PDBsum; 4IAO; -.
DR   AlphaFoldDB; P06700; -.
DR   SMR; P06700; -.
DR   BioGRID; 32017; 405.
DR   ComplexPortal; CPX-1669; RENT complex.
DR   ComplexPortal; CPX-1811; Sir2-3-4 silent chromatin complex.
DR   DIP; DIP-596N; -.
DR   FunCoup; P06700; 232.
DR   IntAct; P06700; 56.
DR   MINT; P06700; -.
DR   STRING; 4932.YDL042C; -.
DR   BindingDB; P06700; -.
DR   ChEMBL; CHEMBL3275; -.
DR   iPTMnet; P06700; -.
DR   PaxDb; 4932-YDL042C; -.
DR   PeptideAtlas; P06700; -.
DR   EnsemblFungi; YDL042C_mRNA; YDL042C; YDL042C.
DR   GeneID; 851520; -.
DR   KEGG; sce:YDL042C; -.
DR   AGR; SGD:S000002200; -.
DR   SGD; S000002200; SIR2.
DR   VEuPathDB; FungiDB:YDL042C; -.
DR   eggNOG; KOG2684; Eukaryota.
DR   GeneTree; ENSGT00940000159406; -.
DR   HOGENOM; CLU_023643_5_0_1; -.
DR   InParanoid; P06700; -.
DR   OMA; MFLKYYG; -.
DR   OrthoDB; 420264at2759; -.
DR   BioCyc; MetaCyc:MONOMER3O-4152; -.
DR   BioCyc; YEAST:MONOMER3O-4152; -.
DR   Reactome; R-SCE-427359; SIRT1 negatively regulates rRNA expression.
DR   SABIO-RK; P06700; -.
DR   BioGRID-ORCS; 851520; 10 hits in 10 CRISPR screens.
DR   EvolutionaryTrace; P06700; -.
DR   PRO; PR:P06700; -.
DR   Proteomes; UP000002311; Chromosome IV.
DR   RNAct; P06700; protein.
DR   GO; GO:0005677; C:chromatin silencing complex; IDA:SGD.
DR   GO; GO:0000781; C:chromosome, telomeric region; IDA:SGD.
DR   GO; GO:0000792; C:heterochromatin; IDA:SGD.
DR   GO; GO:0005730; C:nucleolus; IDA:SGD.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0030869; C:RENT complex; IDA:SGD.
DR   GO; GO:0003688; F:DNA replication origin binding; IDA:SGD.
DR   GO; GO:0017136; F:histone deacetylase activity, NAD-dependent; IDA:SGD.
DR   GO; GO:0032041; F:histone H3K14 deacetylase activity, NAD-dependent; IDA:SGD.
DR   GO; GO:0046969; F:histone H3K9 deacetylase activity, NAD-dependent; IDA:SGD.
DR   GO; GO:0046970; F:histone H4K16 deacetylase activity, NAD-dependent; IDA:SGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0070403; F:NAD+ binding; IBA:GO_Central.
DR   GO; GO:0006325; P:chromatin organization; IDA:SGD.
DR   GO; GO:0006303; P:double-strand break repair via nonhomologous end joining; IMP:SGD.
DR   GO; GO:0097695; P:establishment of protein-containing complex localization to telomere; IMP:SGD.
DR   GO; GO:0031507; P:heterochromatin formation; IBA:GO_Central.
DR   GO; GO:1904524; P:negative regulation of DNA amplification; IMP:SGD.
DR   GO; GO:0045910; P:negative regulation of DNA recombination; IMP:SGD.
DR   GO; GO:0008156; P:negative regulation of DNA replication; IMP:SGD.
DR   GO; GO:0000183; P:rDNA heterochromatin formation; IMP:SGD.
DR   GO; GO:0097752; P:regulation of DNA stability; IMP:SGD.
DR   GO; GO:0031494; P:regulation of mating type switching; IMP:SGD.
DR   GO; GO:0031047; P:regulatory ncRNA-mediated gene silencing; IMP:CACAO.
DR   GO; GO:0030466; P:silent mating-type cassette heterochromatin formation; IMP:SGD.
DR   GO; GO:0007062; P:sister chromatid cohesion; IMP:SGD.
DR   GO; GO:0031509; P:subtelomeric heterochromatin formation; IMP:SGD.
DR   GO; GO:0034398; P:telomere tethering at nuclear periphery; IMP:SGD.
DR   CDD; cd01408; SIRT1; 1.
DR   FunFam; 1.20.120.1710:FF:000001; NAD-dependent histone deacetylase SIR2; 1.
DR   Gene3D; 1.20.120.1710; -; 1.
DR   Gene3D; 3.30.1600.10; SIR2/SIRT2 'Small Domain; 1.
DR   Gene3D; 3.40.50.1220; TPP-binding domain; 1.
DR   InterPro; IPR029035; DHS-like_NAD/FAD-binding_dom.
DR   InterPro; IPR007654; NAD-dep_histone_deAcase_SIR2_N.
DR   InterPro; IPR050134; NAD-dep_sirtuin_deacylases.
DR   InterPro; IPR003000; Sirtuin.
DR   InterPro; IPR026591; Sirtuin_cat_small_dom_sf.
DR   InterPro; IPR026590; Ssirtuin_cat_dom.
DR   PANTHER; PTHR11085:SF9; NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-1; 1.
DR   PANTHER; PTHR11085; NAD-DEPENDENT PROTEIN DEACYLASE SIRTUIN-5, MITOCHONDRIAL-RELATED; 1.
DR   Pfam; PF04574; DUF592; 1.
DR   Pfam; PF02146; SIR2; 1.
DR   SUPFAM; SSF52467; DHS-like NAD/FAD-binding domain; 1.
DR   PROSITE; PS50305; SIRTUIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Chromatin regulator; DNA damage; DNA repair; Metal-binding;
KW   NAD; Nucleus; Reference proteome; Repressor; Transcription;
KW   Transcription regulation; Transferase; Zinc.
FT   CHAIN           1..562
FT                   /note="NAD-dependent histone deacetylase SIR2"
FT                   /id="PRO_0000110280"
FT   DOMAIN          237..527
FT                   /note="Deacetylase sirtuin-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00236"
FT   REGION          1..67
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        11..25
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        26..36
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        364
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00236"
FT   BINDING         262..281
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000269|PubMed:23307867, ECO:0000269|Ref.28"
FT   BINDING         344..347
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P53686"
FT   BINDING         372
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000269|PubMed:23307867, ECO:0000269|Ref.28"
FT   BINDING         375
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000269|PubMed:23307867, ECO:0000269|Ref.28"
FT   BINDING         396
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000269|PubMed:23307867, ECO:0000269|Ref.28"
FT   BINDING         399
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000269|PubMed:23307867, ECO:0000269|Ref.28"
FT   BINDING         471..473
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000269|PubMed:23307867"
FT   BINDING         496..498
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000269|PubMed:23307867"
FT   BINDING         513
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000269|PubMed:23307867"
FT   MUTAGEN         139
FT                   /note="R->K: Defects in telomeric silencing."
FT                   /evidence="ECO:0000269|PubMed:12399383"
FT   MUTAGEN         270
FT                   /note="G->E: Defects in telomeric silencing."
FT                   /evidence="ECO:0000269|PubMed:12399383"
FT   MUTAGEN         296
FT                   /note="F->L: Defects in telomeric silencing."
FT                   /evidence="ECO:0000269|PubMed:12399383"
FT   HELIX           102..105
FT                   /evidence="ECO:0007829|PDB:4IAO"
FT   STRAND          111..113
FT                   /evidence="ECO:0007829|PDB:4IAO"
FT   STRAND          124..126
FT                   /evidence="ECO:0007829|PDB:4IAO"
FT   HELIX           132..154
FT                   /evidence="ECO:0007829|PDB:4IAO"
FT   HELIX           163..170
FT                   /evidence="ECO:0007829|PDB:4IAO"
FT   STRAND          173..175
FT                   /evidence="ECO:0007829|PDB:4IAO"
FT   HELIX           178..187
FT                   /evidence="ECO:0007829|PDB:4IAO"
FT   STRAND          213..217
FT                   /evidence="ECO:0007829|PDB:2HJH"
FT   HELIX           244..253
FT                   /evidence="ECO:0007829|PDB:2HJH"
FT   STRAND          255..261
FT                   /evidence="ECO:0007829|PDB:2HJH"
FT   HELIX           263..269
FT                   /evidence="ECO:0007829|PDB:2HJH"
FT   STRAND          274..276
FT                   /evidence="ECO:0007829|PDB:2HJH"
FT   HELIX           280..283
FT                   /evidence="ECO:0007829|PDB:2HJH"
FT   HELIX           284..287
FT                   /evidence="ECO:0007829|PDB:2HJH"
FT   HELIX           292..296
FT                   /evidence="ECO:0007829|PDB:2HJH"
FT   HELIX           298..303
FT                   /evidence="ECO:0007829|PDB:2HJH"
FT   HELIX           306..311
FT                   /evidence="ECO:0007829|PDB:2HJH"
FT   HELIX           312..315
FT                   /evidence="ECO:0007829|PDB:2HJH"
FT   HELIX           324..334
FT                   /evidence="ECO:0007829|PDB:2HJH"
FT   STRAND          338..343
FT                   /evidence="ECO:0007829|PDB:2HJH"
FT   HELIX           349..352
FT                   /evidence="ECO:0007829|PDB:2HJH"
FT   TURN            357..359
FT                   /evidence="ECO:0007829|PDB:2HJH"
FT   STRAND          360..362
FT                   /evidence="ECO:0007829|PDB:2HJH"
FT   STRAND          365..372
FT                   /evidence="ECO:0007829|PDB:2HJH"
FT   TURN            373..375
FT                   /evidence="ECO:0007829|PDB:2HJH"
FT   STRAND          378..380
FT                   /evidence="ECO:0007829|PDB:2HJH"
FT   HELIX           381..384
FT                   /evidence="ECO:0007829|PDB:2HJH"
FT   HELIX           385..389
FT                   /evidence="ECO:0007829|PDB:2HJH"
FT   TURN            397..399
FT                   /evidence="ECO:0007829|PDB:2HJH"
FT   HELIX           400..406
FT                   /evidence="ECO:0007829|PDB:2HJH"
FT   TURN            417..420
FT                   /evidence="ECO:0007829|PDB:4IAO"
FT   TURN            433..436
FT                   /evidence="ECO:0007829|PDB:2HJH"
FT   STRAND          437..442
FT                   /evidence="ECO:0007829|PDB:2HJH"
FT   HELIX           451..460
FT                   /evidence="ECO:0007829|PDB:2HJH"
FT   TURN            461..463
FT                   /evidence="ECO:0007829|PDB:2HJH"
FT   STRAND          466..471
FT                   /evidence="ECO:0007829|PDB:2HJH"
FT   HELIX           479..481
FT                   /evidence="ECO:0007829|PDB:2HJH"
FT   HELIX           482..485
FT                   /evidence="ECO:0007829|PDB:2HJH"
FT   STRAND          492..498
FT                   /evidence="ECO:0007829|PDB:2HJH"
FT   STRAND          506..511
FT                   /evidence="ECO:0007829|PDB:2HJH"
FT   HELIX           513..524
FT                   /evidence="ECO:0007829|PDB:2HJH"
FT   HELIX           533..537
FT                   /evidence="ECO:0007829|PDB:2HJH"
FT   STRAND          541..547
FT                   /evidence="ECO:0007829|PDB:2HJH"
FT   STRAND          550..555
FT                   /evidence="ECO:0007829|PDB:2HJH"
SQ   SEQUENCE   562 AA;  63262 MW;  52E6937533654586 CRC64;
     MTIPHMKYAV SKTSENKVSN TVSPTQDKDA IRKQPDDIIN NDEPSHKKIK VAQPDSLRET
     NTTDPLGHTK AALGEVASME LKPTNDMDPL AVSAASVVSM SNDVLKPETP KGPIIISKNP
     SNGIFYGPSF TKRESLNARM FLKYYGAHKF LDTYLPEDLN SLYIYYLIKL LGFEVKDQAL
     IGTINSIVHI NSQERVQDLG SAISVTNVED PLAKKQTVRL IKDLQRAINK VLCTRLRLSN
     FFTIDHFIQK LHTARKILVL TGAGVSTSLG IPDFRSSEGF YSKIKHLGLD DPQDVFNYNI
     FMHDPSVFYN IANMVLPPEK IYSPLHSFIK MLQMKGKLLR NYTQNIDNLE SYAGISTDKL
     VQCHGSFATA TCVTCHWNLP GERIFNKIRN LELPLCPYCY KKRREYFPEG YNNKVGVAAS
     QGSMSERPPY ILNSYGVLKP DITFFGEALP NKFHKSIRED ILECDLLICI GTSLKVAPVS
     EIVNMVPSHV PQVLINRDPV KHAEFDLSLL GYCDDIAAMV AQKCGWTIPH KKWNDLKNKN
     FKCQEKDKGV YVVTSDEHPK TL
//
